查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1318912

藥物研發服務市場：按流程、藥物類型、服務類型、治療領域、最終用戶 - 2023-2030 年全球預測

Drug Discovery Services Market by Process, Drug Type, Service type, Therapeutic Area, End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全球藥物研發服務市場預計到2023年將達到217.7億美元，複合年成長率為14.27%，大幅成長，預計到2030年將達到557.5億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球藥物研發服務市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1.藥物研發服務的全球市場規模與預測為何？

2.在預測期內，COVID-19 對全球藥物研發服務市場的阻礙因素和影響為何？

3. 在預測期內，全球藥物研發服務市場需要投資哪些產品/細分市場/應用/領域？

4.你們在全球藥物研發服務市場的競爭策略是什麼？

5. 全球藥物研發服務市場的技術趨勢和法律規範是什麼？

6.全球藥物研發服務市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球藥物研發服務市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 加大醫藥及生物製藥產業研發投入
      • 分析測試和臨床試驗服務外包需求顯著增加
      • 罕見疾病及罕見疾病藥物研究
    • 抑制因素
      • 昂貴的藥物研發發現和開發
    • 機會
      • 專注於生物製劑開發和藥物研發
      • 專利到期的可能性
    • 任務
      • 關於藥物研發和動物使用的嚴格政府法規
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 服務市場：依流程

  • 候選人檢驗
  • 點選讀取識別
  • 潛在客戶最佳化
  • 目標選擇
  • 目標檢驗

第7章 服務市場

  • 生物製品
  • 低分子

第8章 服務市場：依服務類型

  • 生物服務
  • 化學服務

第9章 服務市場

  • 心血管疾病
  • 消化器官系統疾病
  • 神經病學
  • 腫瘤學

第10章 服務市場：依最終用戶分類

  • 學術機構
  • 製藥和生物技術公司

第11章美洲藥物研發服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太藥物研發服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲藥物研發服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭形勢

  • FPNV定位矩陣
  • 市佔率分析：主要企業
  • 競爭情境分析：主要企業

第15章上市公司名單

第16章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-6611A5111690

The Global Drug Discovery Services Market is forecasted to grow significantly, with a projected USD 21.77 billion in 2023 at a CAGR of 14.27% and expected to reach a staggering USD 55.75 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug Discovery Services Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug Discovery Services Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Process, market is studied across Candidate Validation, Hit-to-Lead Identification, Lead Optimization, Target Selection, and Target Validation. The Target Validation is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Biologics and Small Molecules. The Biologics is projected to witness significant market share during forecast period.

Based on Service type, market is studied across Biology Services and Chemistry Services. The Chemistry Services is projected to witness significant market share during forecast period.

Based on Therapeutic Area, market is studied across Cardiovascular Diseases, Digestive System Diseases, Neurology, and Oncology. The Neurology is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Academic Institutes and Pharmaceutical & Biotechnology Companies. The Academic Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug Discovery Services Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug Discovery Services Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug Discovery Services Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug Discovery Services Market?

4. What is the competitive strategic window for opportunities in the Global Drug Discovery Services Market?

5. What are the technology trends and regulatory frameworks in the Global Drug Discovery Services Market?

6. What is the market share of the leading vendors in the Global Drug Discovery Services Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug Discovery Services Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug Discovery Services Market, by Process, 2022 vs 2030
  • 4.3. Drug Discovery Services Market, by Drug Type, 2022 vs 2030
  • 4.4. Drug Discovery Services Market, by Service type, 2022 vs 2030
  • 4.5. Drug Discovery Services Market, by Therapeutic Area, 2022 vs 2030
  • 4.6. Drug Discovery Services Market, by End-user, 2022 vs 2030
  • 4.7. Drug Discovery Services Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing R&D investments in the pharmaceutical & biopharmaceutical industry
      • 5.1.1.2. Attractive rise in demand for outsourcing analytical testing and clinical trial services
      • 5.1.1.3. Research on rare diseases and orphan drugs
    • 5.1.2. Restraints
      • 5.1.2.1. Expensive drug discovery and development
    • 5.1.3. Opportunities
      • 5.1.3.1. Development in the biologics and focus on drug discovery
      • 5.1.3.2. Potential associated with expiry of patents
    • 5.1.4. Challenges
      • 5.1.4.1. Strict government rules for drug discovery and animal usage
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug Discovery Services Market, by Process

  • 6.1. Introduction
  • 6.2. Candidate Validation
  • 6.3. Hit-to-Lead Identification
  • 6.4. Lead Optimization
  • 6.5. Target Selection
  • 6.6. Target Validation

7. Drug Discovery Services Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Biologics
  • 7.3. Small Molecules

8. Drug Discovery Services Market, by Service type

  • 8.1. Introduction
  • 8.2. Biology Services
  • 8.3. Chemistry Services

9. Drug Discovery Services Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Digestive System Diseases
  • 9.4. Neurology
  • 9.5. Oncology

10. Drug Discovery Services Market, by End-user

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Drug Discovery Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Drug Discovery Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Drug Discovery Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. FPNV Positioning Matrix
  • 14.2. Market Share Analysis, By Key Player
  • 14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

  • 16.1. Discussion Guide
  • 16.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DISCOVERY SERVICES MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2022 VS 2030 (%)
  • FIGURE 5. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2022 VS 2030 (%)
  • FIGURE 7. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2030 (%)
  • FIGURE 8. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 9. DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 10. DRUG DISCOVERY SERVICES MARKET DYNAMICS
  • FIGURE 11. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 20. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 21. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG DISCOVERY SERVICES MARKET SIZE, BY CANDIDATE VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT-TO-LEAD IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET SELECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG DISCOVERY SERVICES MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG DISCOVERY SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM DRUG DISCOVERY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 233. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 234. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 235. DRUG DISCOVERY SERVICES MARKET LICENSE & PRICING